Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Acumen Pharmaceuticals Inc shares valued at $87,873 were sold by OConnell Daniel Joseph on Jan 03 ’25. At $1.84 per share, OConnell Daniel Joseph sold 47,778 shares. The insider’s holdings dropped to 454,707 shares worth approximately $0.77 million following the completion of this transaction.
Also, Meisner Derek M sold 11,122 shares, netting a total of over 20,506 in proceeds. Following the sale of shares at $1.84 each, the insider now holds 97,745 shares.
Before that, Barton Russell had sold 7,636 shares from its account. In a trade valued at $14,225, the Chief Operating Officer traded Acumen Pharmaceuticals Inc shares for $1.86 each. Upon closing the transaction, the insider’s holdings decreased to 7,636 shares, worth approximately $0.15 million.
As published in their initiating research note from Citigroup on July 26, 2024, Acumen Pharmaceuticals Inc [ABOS] has been a Buy and the price target has been revised to $7. Analysts at Deutsche Bank started covering the stock with ‘”a Buy”‘ outlook in a report released in mid December. Earlier on May 18, 2023, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for ABOS stock.
Analyzing ABOS Stock Performance
During the last five days, there has been a drop of approximately -1.16%. Over the course of the year, Acumen Pharmaceuticals Inc shares have dropped approximately -1.16%. Shares of the company reached a 52-week high of $1.9500 on 01/06/25 and a 52-week low of $1.7000 on 01/08/25. A 50-day SMA is recorded $2.3089, while a 200-day SMA reached $2.7676. Nevertheless, trading volume fell to 0.23 million shares from 0.18 million shares the previous day.
Support And Resistance Levels for Acumen Pharmaceuticals Inc (ABOS)
According to the 24-hour chart, there is a support level at 1.6633, which, if violated, would cause prices to drop to 1.6267. In the upper region, resistance lies at 1.7733. The next price resistance is at 1.8467. RSI (Relative Strength Index) is 35.13 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0117, which suggests the price will decrease in the coming days. Percent R is at 96.43%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
